Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanyan Meng

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Biomaterials|May 17, 2024
Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumorsTianyu Shi, Mengna Sun, Subiyinuer Tuerhong, et al.
The Journal of Clinical Investigation|March 6, 2019
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumorsFangjun Chen, Zhengyun Zou, Juan Du, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2025
Verteporfin-Mediated In Situ Nanovaccine Based on Local Conventional-Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory EffectZhifan Zhang, Lin Li, Yuchen Ge, et al.
Nature Communications|November 8, 2019
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogrammingFanyan Meng, Ling Wu, Lun Dong, et al.
Frontiers in Oncology|June 23, 2022
Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic CancerChangchang Lu, Yahui Zhu, Hao Cheng, et al.
Frontiers in Oncology|September 5, 2022
Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancerChangchang Lu, Yahui Zhu, Weiwei Kong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 9, 2023
Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid TumorsXinyue Wang, Fanyan Meng, Xiang Li, et al.
Aging and Disease|April 8, 2020
Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 PneumoniaZikuan Leng, Rongjia Zhu, Wei Hou, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Biomaterials|May 17, 2024
Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumorsTianyu Shi, Mengna Sun, Subiyinuer Tuerhong, et al.
The Journal of Clinical Investigation|March 6, 2019
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumorsFangjun Chen, Zhengyun Zou, Juan Du, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2025
Verteporfin-Mediated In Situ Nanovaccine Based on Local Conventional-Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory EffectZhifan Zhang, Lin Li, Yuchen Ge, et al.
Nature Communications|November 8, 2019
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogrammingFanyan Meng, Ling Wu, Lun Dong, et al.
Frontiers in Oncology|June 23, 2022
Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic CancerChangchang Lu, Yahui Zhu, Hao Cheng, et al.
Frontiers in Oncology|September 5, 2022
Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancerChangchang Lu, Yahui Zhu, Weiwei Kong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 9, 2023
Nanomodified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid TumorsXinyue Wang, Fanyan Meng, Xiang Li, et al.
Aging and Disease|April 8, 2020
Transplantation of ACE2<sup>-</sup> Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 PneumoniaZikuan Leng, Rongjia Zhu, Wei Hou, et al.
Pageof 9